Thirteen years survival in a patient with isolated skin metastases of a gastric carcinoma. What kind of disease is that?;Supervivencia de trece años en una paciente con metástasis cutáneas aisladas de adenocarcinoma gástrico. ¿Ante qué enfermedad nos encontramos?

Anales de Medicina Interna

Volumn 20, Issue 5, 2003, Pages 251-253

  Segura Huerta, Ángel ^a   Perez Fidalgo J A ^a   Lopez Tendero P ^a   Girones Sarrio R ^a   Aparicio Urtasun, J ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Gastric carcinoma; Long time survival; Prognostic factors; Skin metastases

Indexed keywords

CISPLATIN; CYTOSTATIC AGENT; ETOPOSIDE; FLUOROURACIL; FOLIC ACID;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CASE REPORT; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; HUMAN; PROGNOSIS; SKIN METASTASIS; STOMACH ADENOCARCINOMA; STOMACH CARCINOMA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SIGNET RING CELL; CISPLATIN; COBALT RADIOISOTOPES; COMBINED MODALITY THERAPY; ETOPOSIDE; FATAL OUTCOME; FEMALE; FLUOROURACIL; GASTROENTEROSTOMY; HUMANS; LEUCOVORIN; MIDDLE AGED; RADIOISOTOPE TELETHERAPY; SHOULDER; SKIN NEOPLASMS; STOMACH NEOPLASMS; STOMACH ULCER; SURVIVORS;

EID: 0037937223     PISSN: 02127199     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Factores pronósticos del cáncer gástrico. En: González-Barón M. y cols (ed). Cáncer Gástrico. Documentos Consenso Oncología. Noviembre, 1999.
2. Roder JD, Bottcher K, Siewert JR y cols. Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study 1992. Cancer 1993; 72: 2089-2097.
3. Muino Minguez A, Polo Casado A, Donis Sevillano E et al. Metástasis cutáneas como presentación de cáncer de origen desconocido. An Med Interna (Madrid) 1986; 10: 442-443.
4. Jurado Gámez B, Hidalgo Nuchera E, Merino Romero J. Metástasis cutáneas, presentación inusual del cáncer de pulmón. An Med Interna (Madrid) 1995; 12: 346-348.
5. Franco Vicario R, Tirapu JM, Escalente J et al. Carcinoma epidermoide pulmonar en paciente de 22 años con metástasis cutáneas múltiples. An Med Interna (Madrid) 1998; 15: 591-593.
6. Mac Donald JS, Steele G, Gunderson L. Cancer of the stomach. En: DeVita VT, Hellman S, Rosemberg SA. Principles of Clinical Oncology.
7. Pestalozi BC, Von Hochstetter AR. Muscle metastasis as initial manifestation af adenocarcinoma of the stomach. Schweiz Med Wonchenschr 1998-00; 128: 38, 1414-7.
8. Kajiyama Y, Tsurumaru M, Udagawa H et al. Prognostic factors in adenocarcinoma of the gastric cardia: pathologic stage anlysus and multivariate regression analysis. J Clin Oncol 1997; 15: 2015-2021.
9. Kimura H, Yonemura Y. Flow cytometric analysis of nuclear DNA content in advanced gastric cancer and its relation to prognosis. Cancer 1991; 67: 2588-2593.
10. Tahara E, Semba S, Tahara H. Molecular Biological observations in gastric cancer. Semin Oncol 1996; 23: 307-315.
11. Heiss MM, Babic R, Allgayer H y cols. Tumor-associated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urodinase-type plasminogen activator system. J Clin Oncol 1995; 13: 2084-2093.
12. Nekarda H, Schmitt M, Ulm K y cols. Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric carcinoma. Cancer Res 1994; 54: 2900-2907.
13. Yonemura Y, Fujimura T, Fushida S y cols. Peritonectomy for advanced gastric cancer. En: Yutaka Y (ed.): Peritoneal dissemination. Kanazawa, Japón: Maeda Shoten Co Ltd 1998; 275-293.
14. Ochiai T, Sasako M, Mizumo S y cols. Hepatic resection for metastatic tumours from gastric cancer: analysis of prognostic factors. Br J Surg 1994; 81: 1175-1178.
15. Lindell G, Ohlsson B, Saarela A y cols. Liver resection of non-colorectal secondaries. J Surg Oncol 1008; 69: 66-70.